COVID-19 Vaccine and Treatment Toolkit for Post-Acute and Long-Term Care Released
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
COVID19
Patients, Clinicians Explain How the Pandemic Affected Genitourinary Cancer Care
A focus group sought to explore the effects of the changes in genitourinary cancer care during the COVID-19 pandemic from the perspective of patients and clinicians.
FDA Authorizes Emergency Use of Kineret for Certain Hospitalized COVID-19 Patients
Kineret is an interleukin-1 receptor antagonist.
Certain Omicron Subvariants May Be Resistant to Bebtelovimab
Bebtelovimab is currently authorized for emergency use for the treatment of mild to moderate COVID-19 in adults and pediatric patients.
Fewer Serious Adverse Events Reported in Cancer Trials During COVID-19 Pandemic
Serious adverse events were reported less frequently among patients enrolled in cancer trials during the first 2 years of the COVID-19 pandemic than among patients enrolled prior to the pandemic.
Finerenone May Protect Against Pneumonia and COVID-19
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.
COVID-19 Vaccines Reduce Risk of Severe Outcomes in CKD
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
Nearly Half of Adults Not Planning or Hesitant to Get Flu Vaccine
NFID survey show beliefs about influenza and pneumococcal disease, as well as attitudes and practices around vaccination, including the impacts of the COVID-19 pandemic.
Real-World Data Provide Insight Into Oral COVID-19 Antiviral Molnupiravir
Molnupiravir is a nucleoside analogue that inhibits SARS-CoV-2 replication by viral mutagenesis.
COVID-19 Vaccines Not Associated With Increased Risk for SLE Flares
The aim of the study was to evaluate the occurrence of SLE flares after COVID-19 vaccination.
- Loading...
Loading...
Next post in Rheumatology
Loading... 
Loading...